Notice regarding additions to the Formulary of Topical Ocular Pharmaceutical Agents

Effective 12/7/25: 

The Florida Board of Optometry approved acoltremon ophthalmic solution 0.003%  (TRYPTYR) and aceclidine 1.44% ophthalmic solution (VIZZ) for addition to Rule 64B13-18.002, F.A.C.. Effective December 7, 2025, licensees are now permitted to prescribe acoltremon ophthalmic solution 0.003%  (TRYPTYR) and aceclidine 1.44% ophthalmic solution (VIZZ).

An official website of the State of Florida How You Know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you’ve safely connected to the .gov website. Share sensitive information only on official, secure websites.

Latest News

Notice regarding additions to the Formulary of Topical Ocular Pharmaceutical Agents

Effective 12/7/25: 

The Florida Board of Optometry approved acoltremon ophthalmic solution 0.003%  (TRYPTYR) and aceclidine 1.44% ophthalmic solution (VIZZ) for addition to Rule 64B13-18.002, F.A.C.. Effective December 7, 2025, licensees are now permitted to prescribe acoltremon ophthalmic solution 0.003%  (TRYPTYR) and aceclidine 1.44% ophthalmic solution (VIZZ).